Clinical trial
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients…
NCT00345501 · Onassis Cardiac Surgery Centre, Other · Completed
Key facts
| NCT number | NCT00345501 |
|---|---|
| Title | Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention |
| Official title | Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients With Preexisting Renal Dysfunction Undergoing a Coronary Procedure |
| Lead sponsor | Onassis Cardiac Surgery Centre, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Renal Insufficiency, Chronic, Coronary Angiography, Angioplasty, Transluminal, Percutaneous Coronary |
| Intervention type | Drug |
| Interventions | Iloprost, Placebo |
| Enrollment | 208 |
| Start date | Nov 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Jun 28, 2006 |
| Last update posted | Aug 24, 2007 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: